---
schema_version: "secwatch.filing_event.v1"
accession: "0001096906-23-002456"
form_type: "8-K"
ticker: "AXIM"
cik: "0001514946"
company_name: "AXIM BIOTECHNOLOGIES, INC."
filed_at: "2023-12-28T23:59:59+00:00"
generated_at: "2026-06-07T06:20:28.854501+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Axim Biotech enters up to $750K convertible note deal with affiliate Medical Marijuana Inc

## Summary
- Initial $100,000 note issued Dec 26, 2023; MJNA can purchase up to $750,000 total by June 26, 2025.
- Notes bear 5.25% interest, mature Dec 26, 2033; interest payable annually starting Dec 26, 2024.
- Conversion price is lesser of $0.01 or 70% of avg two lowest closing prices in prior 10 trading days.
- Conversion capped at 4.9% beneficial ownership; notes sold unregistered under Regulation D.
- Proceeds for working capital, product development, and clinical trials.

## SEC filing metadata
- accession: 0001096906-23-002456
- form_type: 8-K
- ticker: AXIM
- cik: 0001514946
- company_name: AXIM BIOTECHNOLOGIES, INC.
- filed_at: 2023-12-28T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514946/000109690623002456/0001096906-23-002456-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514946/000109690623002456/axim-20231226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001096906-23-002456
- JSON: https://secwatch.observer/filing/0001096906-23-002456.json
- Plain text: https://secwatch.observer/filing/0001096906-23-002456.txt

## Key facts
- Material Agreements
  AXIM BIOTECHNOLOGIES, INC. entered into Convertible Note Purchase Agreement with Medical Marijuana, Inc valued at $750,000 (effective 2023-12-26).
  - Action: entry
  - Agreement: notes offering
  - Counterparty: Medical Marijuana, Inc
  - Value: $750,000
  - Effective: 2023-12-26
  source text: Effective December 26, 2023, AXIM Biotechnologies, Inc. (the “Company”) entered into a Convertible Note Purchase Agreement (the "Agreement") with Medical Marijuana, Inc (“MJNA”), currently an affiliate of the Company and one of its largest shareholders, for the purchase of up to $750,000 face value in convertible notes.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1514946/000109690623002456/0001096906-23-002456-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.